Day: May 13, 2022

Clearmind aims to initiate clinical trials with CMND-100 by year’s end Vancouver, May 13, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under treated health problems, today announced that it will meet with the Center for Drug Evaluation and Research (“CDER”) of the U.S. Food and Drug Administration (“FDA”) on Wednesday, May 18, 2022. The meeting is to discuss numerous aspects of Clearmind’s planned First in Human (“FIH”) study evaluating its proprietary drug candidate CMND-100 for the treatment of Alcohol Use Disorder (“AUD”). Clearmind’s CEO, Dr. Adi Zuloff-Shani, commenting on the meeting said “The meeting with the FDA is an important...

Phillipsburg, NJ , May 13, 2022 (GLOBE NEWSWIRE) — Today, OMID Holdings, Inc. (OTC Pink: OMID) posted its Unaudited Financial & Disclosure Statements for the Three Months Ended March 31, 2022. During the period, OMID realized record first-quarter revenue; some notable financial highlights are further detailed below. Highlighted Operating Results for the First Quarter of 2022Revenue for 1Q2022 was $358,772 compared to $278,124 for 1Q2021, a 29% improvement from the comparative quarter in the previous year. Gross Profit for 1Q2022 was $175,247 compared to $139,126 for 1Q2021, a 26% improvement from the comparative quarter in the previous year. Net Income before income taxes for 1Q2022 was $75,209 compared to $47,525 for the 1Q2021, a 58% improvement from the comparative quarter in the previous year.                                                                 ...

COLUMBUS, Ohio, May 13, 2022 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) announced today the declaration of its regular quarterly dividend of $0.20 per share payable on June 17, 2022 to shareholders of record at the close of business on June 3, 2022. ABOUT BATH & BODY WORKS: Bath & Body Works is one of the world’s leading specialty retailers and home to America’s Favorite Fragrances® offering a breadth of exclusive fragrances for the body and home, including the #1 selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. For more than 30 years, customers have looked to Bath & Body Works for quality, on-trend products and the newest, freshest fragrances. Today, these fragrant products can be purchased at more than 1,750...

Courcy Drill Hole Location Map Courcy Drill Hole Location MapQUEBEC CITY, May 13, 2022 (GLOBE NEWSWIRE) — Stelmine Canada (TSXV: STH) (“Stelmine” or the “Company”) is pleased to announce that the Company has completed Phase 1 drilling at its 100%-owned Courcy Project where the target is near-surface gold mineralization in a vastly under-explored part of northern Quebec with district scale potential. Highlights:A total of 14 drill holes comprising 2,237 metres were completed in Phase 1; Twelve of the 14 holes tested Zone 1. Three of those holes intersected visible gold including STH21-COU12 collared 300 metres east of SOQUEM’s 2006 discovery hole that returned 42 m grading 4.2 g/t Au; Stelmine drilling has significantly extended the prospective gold system in Zone 1 to at least 300 metres along the Couteau Fault; Multiple additional...

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announces that certain members of its Board of Directors and Management team (the “Insiders”) have informed the Company of their intention, on an individual basis and not in concert, to use their personal funds to purchase approximately 2.5% of the Company’s common shares outstanding. The Insiders may purchase approximately 750,000 common shares (the “Securities”) on the open market, representing approximately 2.5% of basic common shares outstanding within the one-month period commencing May 16, 2022. Any Insider purchase will be conducted in compliance with the Company’s insider trading policy and Insiders will meet the SEC reporting obligations. Insiders’ proposed purchases...

VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI; OTCQB: RSSFF) is pleased to announce that it has submitted a program enrollment form and paid applicable fees for CanadaGAP® food safety certification. The CanadaGAP® program is open to companies involved in production, handling and brokerage of fresh fruits and vegetables who need to demonstrate to their customers that they are implementing food safety programs and/or following the CanadaGAP® manuals. This is another milestone for Affinor which completes the final phase of commercialization. The company has been focused on quality and timely delivery of strawberries to fresh local markets in Vancouver and is now focused on expansion to satisfy strong demand. Affinor is in the process of permitting their new...

Top-Ranked, Regional Bank Adds Two Local Bank Leaders CHARLOTTE, N.C., May 13, 2022 (GLOBE NEWSWIRE) — ServisFirst Bank, a subsidiary of ServisFirst Bancshares (NYSE:SFBS), announces the addition of two seasoned, Charlotte-native bankers to ServisFirst Bank Piedmont. Craig May, III will serve as Charlotte Regional President and Robert Shell, II joins the team as Executive Vice President, Chief Credit Officer. “We are proud to welcome Craig and Rob to the ServisFirst Bank team,” states Rick Manley, ServisFirst Bank Piedmont Regional CEO. “These two Charlotte-natives have extensive business and banking experience that will enable us to provide the Charlotte market and clients with the superior service ServisFirst Bank has come to be known for.” Craig May, III, Charlotte Regional PresidentCraig May joins ServisFirst Bank Piedmont...

SOLANA BEACH, Calif., May 13, 2022 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it will present investigational research and exhibit at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in Washington, DC. The research abstract to be presented in the poster session, entitled AAV Vectors – Preclinical and Proof-of-Concept, will focus on lessons learned using convection-enhanced delivery to infuse gene therapy products in the pre-clinical setting. Lead author Dr. Ernesto Salegio, the Company’s Vice President, Segment Leader for Translational & Pre-Clinical Research, will present the poster on Monday, May 16th at 5:30 PM Eastern Time. Conference attendees...